Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles
Teeth Whitening

InDex Pharmaceuticals AB Engages PharmaVentures To Facilitate The Licensing Of Kappaproct(R) After Phase IIa Trial Achieves Clinical Endpoints Early
PharmaVentures Ltd, announced that it has been engaged by InDex Pharmaceuticals AB to advise and assist in out-licensing its first in class therapeutic, Kappaproct (DIMS 0150), for the treatment of steroid resistant / dependent Inflammatory Bowel Disease (IBD). The engagement will utilise PharmaVentures" transactions experience in the healthcare and investment business sectors.
generic viagra online
Infants Experience Errors In Heart Meds Most Often
Infants and young children treated with heart drugs get the wrong dose or end up on the wrong end of medication errors more often than older children, according to research led by the Johns Hopkins Children"s Center published July 6 in Pediatrics.
plastic surgery before after
News of the day
New York Times Examines Debate Surrounding Use Of Experimental Treatments In Terminally Ill Patients
Some patient advocates are lobbying to legalize "compassionate use" of experimental drugs for people with terminal illnesses who have exhausted other treatments, prompting a debate about how and when to provide such patients with treatments that could prolong their lives, the New York Times reports. Most insurers do not cover unproven treatments, and physicians have concerns that using experimental treatment could give patients false hope and cause unnecessary pain. Drugmakers are concerned that if there are unfavorable outcomes from providing patients with an unproven treatment, it could hurt the drug"s chances of receiving FDA approval. At the same time, FDA does not want to grant drugs and their makers the opportunity to skip clinical trials. Currently, patients must individually apply to receive treatments through compassionate use (Harmon, New York Times, 5/17).
Sexual Health

Singer Elton John Calls For Increased HIV/AIDS Education, Care

Singer Elton John on Tuesday at the 2009 Bio International Convention in Atlanta called for renewed efforts to fight HIV/AIDS, the Atlanta Journal-Constitution reports. John, founder of the Elton John AIDS Foundation, addressed an audience that included CEOs of organizations working to develop HIV/AIDS therapies and vaccines. He called on governments and institutions to increase their focus on education, especially among young people; access to medical treatment; and needle-exchange programs (Poole, Atlanta Journal-Constitution, 5/19)."There are long-standing stereotypes and prejudices that inhibit our efforts to combat AIDS," John said, adding, "I am asking for your leadership." According to John, CDC estimates that one in every three new HIV cases occurs among people younger than age 30, a statistic that he said has not received adequate attention. "It is unfathomable and unconscionable that we are not making a bigger effort to educate this demographic about HIV/AIDS with creative materials and up-to-date information," John said, adding, "Our failure to do so is costing lives" (Turner, AP/PennLive.com, 5/19). John also noted a recent report by the Kaiser Family Foundation, which found that the number of Americans who believe HIV/AIDS is an urgent health problem has declined to 6% currently from 44% in 1995. Bob McNally, CEO of GeoVax Labs, said John"s message is that "just not enough is being done" and that "people continue to die from the disease." He added that John "spurred the audience towards being advocates" (Atlanta Journal-Constitution, 5/20). Reprinted with kind permission from http://www.kaisernetwork.org. You can view the entire Kaiser Daily Health Policy Report, search the archives, or sign up for email delivery at http://www.kaisernetwork.org/dailyreports/healthpolicy. The Kaiser Daily Health Policy Report is published for kaisernetwork.org, a free service of The Henry J. Kaiser Family Foundation. © 2009 Advisory Board Company and Kaiser Family Foundation. All rights reserved.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009